title: [Hepatitis C virus genotype 5 in Mexico: a case report with successful treatment and a literature review].
abstract: Hepatitis C virus (HCV) genotype 5 is extremely rare and there is very little reported on its management in the medical literature. We present herein the case of a patient with HCV genotype 5 that presumably acquired the disease through a blood transfusion during infancy. Sustained virologic response was achieved after 24 weeks of treatment. According to the available information on HCV genotype 5 treatment, it has a similar response to that of HCV genotype 1. Our patient presented with various favorable outcome factors. There is much less reported on the treatment of HCV genotype 5 than there is regarding HCV genotypes 1, 2, 3, and 4. This is mainly due to the low prevalence of genotype 5 in the Mexican environment.
authors: Coordinación Clínica de Educación e Investigación en Salud, Hospital General de Zona N.° 58 «General Manuel Ávila Camacho», Instituto Mexicano del Seguro Social, Tlalnepantla de Baz, Estado de México, México. Electronic address: amadel24@hotmail.com.
authors: M A
authors: MA
authors: Rubio-Lezama
authors: R
authors: R
authors: López-Alférez
authors: L
authors: L
authors: Santillán-Arreygue
authors: M
authors: M
authors: Romero-Figueroa
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000453:epidemiology / Q000628:therapy* / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008800:Mexico / Q000453:epidemiology; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin
keywords: Blood-borne disease; Enfermedades de transmisión sanguínea; Epidemiology; Epidemiología; Management; Manejo; Respuesta virológica sostenida; Sustained virologic response